Nanotechnology in medicine and biology / (Record no. 82660)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05729cam a2200505 i 4500 |
| 001 - CONTROL NUMBER | |
| control field | on1285779191 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20230516170002.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu---unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 211120s2022 ne o 000 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | EBLCP |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | EBLCP |
| Modifying agency | YDX |
| -- | YDXIT |
| -- | N$T |
| -- | OCLCQ |
| -- | OPELS |
| -- | OCLCO |
| -- | AMH |
| -- | OCLCQ |
| 019 ## - | |
| -- | 1285452207 |
| -- | 1285494784 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0128226714 |
| Qualifying information | (electronic book) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780128226711 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 0128194693 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9780128194690 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1285779191 |
| Canceled/invalid control number | (OCoLC)1285452207 |
| -- | (OCoLC)1285494784 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | R857.M3 |
| Item number | N35 2022eb |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 610.284 |
| Edition number | 23 |
| 245 00 - TITLE STATEMENT | |
| Title | Nanotechnology in medicine and biology / |
| Statement of responsibility, etc. | edited by Huinan H. Liu, Tolou Shokuhfar, Sougata Ghosh. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Amsterdam, Netherlands ; |
| -- | Oxford, United Kingdom ; |
| -- | Cambridge, MA : |
| Name of producer, publisher, distributor, manufacturer | Elsevier, |
| Date of production, publication, distribution, manufacture, or copyright notice | [2022] |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (296 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Elsevier Series on Advanced Topics in Biomaterials |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- Nanotechnology in Medicine and Biology -- Copyright -- Contents -- Contributors -- Preface -- Chapter 1 Nanobiomaterials for three-dimensional bioprinting -- 1.1 Introduction -- 1.2 Inkjet bioprinting -- 1.3 Bioplotting -- 1.4 Fused-deposition modeling -- 1.5 Selective laser sintering -- 1.6 Stereolithography -- 1.7 3D printing for complex tissue and organ regeneration -- 1.7.1 Bone -- 1.7.2 Cartilage and osteochondral tissue -- 1.7.3 Neural tissue -- 1.7.4 Vascular tissue -- 1.7.5 Organs -- 1.8 4D printing -- 1.9 Conclusion and future perspectives -- Acknowledgments |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc. note | References-Chapter 2 Nanobiomaterials for drug delivery and theranostics-2.1 Introduction-2.2 Design parameters of nanomedicine for drug delivery and theranostics-2.3 Targeted drug delivery for cancer therapy-2.3.1 Passive targeting-2.3.2 Active targeting-2.3.2.1 Tumor cell targeting-2.3.2.2 Vascular targeting (anti-angiogenesis)-2.4 Toxicity of nanobiomaterials-2.5 Biodegradable nanomaterials used in controlled drug delivery and imaging-2.5.1 Organic and polymer-based nanocarriers-2.5.1.1 Liposomes-2.5.1.2 Biodegradable polymer-based nanocarriers. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 2.5.1.3 Dendrimers -- 2.5.2 Inorganic nanobiomaterials for drug delivery and imaging -- 2.5.2.1 Carbon-based nanomaterials -- i) Fullerenes -- ii) Carbon nanotubes -- iii) Graphene and graphene oxide -- 2.5.2.2 Gold nanoparticles -- 2.5.2.3 Magnetic nanoparticles -- 2.5.2.4 Quantum dots -- 2.5.2.5 Mesoporous silica nanoparticles -- 2.6 Conclusion and future perspectives -- References -- Chapter 3 Nanobiomaterials in hard tissue repair -- 3.1 Introduction -- 3.2 Biomaterials in hard tissue engineering -- 3.2.1 Problems in biomaterials -- 3.2.2 Why nanobiomaterials are a potential solution? |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 3.3 Nanobiomaterials in tissue engineering -- 3.3.1 Polymeric nanobiomaterials -- 3.3.1.1 Polymers of natural origin -- 3.3.1.2 Synthetic polymers -- 3.3.2 Ceramic nanobiomaterials -- 3.3.2.1 Bioceramics -- 3.3.2.2 Bioglass: Bioactive ceramic materials -- 3.3.3 Metallic nanobiomaterials -- 3.3.4 Nanobiomaterials from carbon -- 3.3.5 Nanobiomaterial composites -- 3.4 Role of stem cells -- 3.5 Conclusion and future perspectives -- References -- Chapter 4 Application of nanobiomaterials in soft tissue engineering -- 4.1 Introduction -- 4.2 Tissue engineering |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 4.2.1 Nanotechnology in scaffold designing -- 4.2.2 Nanobiomaterials in soft tissue regeneration -- 4.3 Nanobiomaterials in cartilage tissue engineering -- 4.3.1 Cartilage tissue -- 4.3.2 Rationale for cartilage tissue engineering -- 4.3.3 Cartilage tissue engineering -- 4.3.4 Nanobiomaterials in cartilage tissue engineering -- 4.3.4.1 Nanofibers in cartilage tissue engineering -- 4.3.4.2 Nanocomposites in cartilage tissue engineering -- 4.4 Nanobiomaterials in tendon/ligament tissue engineering -- 4.4.1 Tendon/ligament tissue -- 4.4.2 Rationale for tendon/ligament tissue engineering |
| 500 ## - GENERAL NOTE | |
| General note | 4.4.3 Nanobiomaterials in tendon/ligament tissue engineering. |
| 588 0# - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Online resource; title from digital title page (viewed on December 30, 2021). |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Nanotechnology in Medicine and Biology brings together a multidisciplinary team of experts from the fields of materials science, nanotechnology, medicine and biomedical engineering to introduce new nanoscale biomaterials and their applications, diagnosis and treatment of disorders of the human body. The book presents the fundamentals for understanding the design, properties and selection of nanobiomaterials as well as their real-world applications in medicine. Each chapter addresses current regulations, manufacturing processes, and translation issues of nanobiomaterials for key applications. A discussion of current protocols and their benefits and disadvantages is also included. This book provides comprehensive background and knowledge in the field of nanobiomaterials that is suitable for academics, scientists and clinicians. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomedical materials |
| General subdivision | Technological innovations. |
| 9 (RLIN) | 69669 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomat�eriaux |
| Authority record control number or standard number | (CaQQLa)201-0025723 |
| General subdivision | Innovations. |
| Authority record control number or standard number | (CaQQLa)201-0379286 |
| 9 (RLIN) | 69670 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Huinan, |
| Relator term | editor. |
| 9 (RLIN) | 69671 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shokuhfar, Tolou, |
| Relator term | editor. |
| 9 (RLIN) | 69672 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ghosh, Sougata, |
| Relator term | editor. |
| 9 (RLIN) | 69673 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Liu, Huinan. |
| Title | Nanotechnology in Medicine and Biology. |
| Place, publisher, and date of publication | San Diego : Elsevier, �2021 |
| International Standard Book Number | 9780128194690 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Elsevier Series on Advanced Topics in Biomaterials |
| 9 (RLIN) | 69674 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Materials specified | ScienceDirect |
| Uniform Resource Identifier | <a href="https://www.sciencedirect.com/science/book/9780128194690">https://www.sciencedirect.com/science/book/9780128194690</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | eBooks |
No items available.